Less NMDA Receptor Binding in Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex Associated With Reported Early-Life Adversity but Not Suicide

Abstract Background Glutamate is an excitatory neurotransmitter binding to 3 classes of receptors, including the N-methyl, D-aspartate (NMDA) receptor. NMDA receptor binding is lower in major depression disorder and suicide. NMDA receptor blocking with ketamine can have antidepressant and anti-suicide effects. Early-life adversity (ELA) may cause glutamate-mediated excitotoxicity and is more common with major depression disorder and in suicide decedents. We sought to determine whether NMDA-receptor binding is altered with suicide and ELA. Methods A total 52 postmortem cases were organized as 13 quadruplets of suicide and non-suicide decedents matched for age, sex, and postmortem interval, with or without reported ELA (≤16 years). Tissue blocks containing dorsal prefrontal (BA8), dorsolateral prefrontal (BA9), or anterior cingulate (BA24) cortex were collected at autopsy. Psychiatrically healthy controls and suicide decedents underwent psychological autopsy to determine psychiatric diagnoses and details of childhood adversity. NMDA receptor binding was determined by quantitative autoradiography of [3H]MK-801 binding (displaced by unlabeled MK-801) in 20-µm-thick sections. Results [3H]MK-801 binding was not associated with suicide in BA8, BA9, or BA24. However, [3H]MK-801 binding with ELA was less in BA8, BA9, and BA24 independent of suicide (P < .05). [3H]MK-801 binding was not associated with age or postmortem interval in any brain region or group. Conclusions Less NMDA receptor binding with ELA is consistent with the hypothesis that stress can cause excitotoxicity via excessive glutamate, causing either NMDA receptor downregulation or less receptor binding due to neuron loss consequent to the excitotoxicity.

[1]  P. Courtet,et al.  Childhood maltreatment and risk for suicide attempts in major depression: a sex-specific approach , 2019, European journal of psychotraumatology.

[2]  J. Mann,et al.  Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial. , 2017, The American journal of psychiatry.

[3]  G. Turecki,et al.  Neuropathology of suicide: recent findings and future directions , 2017, Molecular Psychiatry.

[4]  T. Ehring,et al.  Childhood maltreatment and characteristics of adult depression: Meta-analysis , 2017, British Journal of Psychiatry.

[5]  J. Savitz,et al.  Neuropathology of mood disorders: do we see the stigmata of inflammation? , 2016, Translational psychiatry.

[6]  Runa Bhaumik,et al.  Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients , 2016, Psychiatry Research.

[7]  B. Dean,et al.  Changes in cortical N-methyl-d-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide , 2016, The Australian and New Zealand journal of psychiatry.

[8]  W. Goodman,et al.  Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial , 2015, Psychological Medicine.

[9]  M. Pompili,et al.  NMDA receptor antagonists for depression: Critical considerations. , 2015, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[10]  J. Krystal,et al.  Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. , 2015, Annual review of medicine.

[11]  F. Perera,et al.  DNA methylation of BDNF as a biomarker of early-life adversity , 2014, Proceedings of the National Academy of Sciences.

[12]  M. Furey,et al.  Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. , 2014, Journal of psychiatric research.

[13]  M. Szyf,et al.  The Consequences of Early‐Life Adversity: Neurobiological, Behavioural and Epigenetic Adaptations , 2014, Journal of neuroendocrinology.

[14]  D. de Leo,et al.  Oral ketamine augmentation for chronic suicidality in treatment-resistant depression. , 2014, The Australian and New Zealand journal of psychiatry.

[15]  D. Luckenbaugh,et al.  Clinical predictors of ketamine response in treatment-resistant major depression. , 2014, The Journal of clinical psychiatry.

[16]  D. Charney,et al.  EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT‐RESISTANT DEPRESSION , 2014, Depression and anxiety.

[17]  R. Dantzer,et al.  Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? , 2014, Journal of Neural Transmission.

[18]  J. Lambert,et al.  Dysfunctional Astrocytic and Synaptic Regulation of Hypothalamic Glutamatergic Transmission in a Mouse Model of Early-Life Adversity: Relevance to Neurosteroids and Programming of the Stress Response , 2013, The Journal of Neuroscience.

[19]  A. Biegon,et al.  Hippocampal Glutamate NMDA Receptor Loss Tracks Progression in Alzheimer’s Disease: Quantitative Autoradiography in Postmortem Human Brain , 2013, PLoS ONE.

[20]  J. Vetulani Early maternal separation: a rodent model of depression and a prevailing human condition , 2013, Pharmacological reports : PR.

[21]  G. Pandey Biological basis of suicide and suicidal behavior , 2013, Bipolar disorders.

[22]  Teresa A. Victor,et al.  Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities , 2013, Brain, Behavior, and Immunity.

[23]  P. Honsa,et al.  Send Orders of Reprints at Reprints@benthamscience.net Nmda Receptors in Glial Cells: Pending Questions , 2022 .

[24]  S. Andersen,et al.  Evidence for a neuroinflammatory mechanism in delayed effects of early life adversity in rats: Relationship to cortical NMDA receptor expression , 2013, Brain, Behavior, and Immunity.

[25]  Kelly A. Bordner,et al.  Maternal separation with early weaning: A rodent model providing novel insights into neglect associated developmental deficits , 2012, Development and Psychopathology.

[26]  G. Laje,et al.  Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression , 2012, Biological Psychiatry.

[27]  Victoria Arango,et al.  Neuron density and serotonin receptor binding in prefrontal cortex in suicide. , 2012, The international journal of neuropsychopharmacology.

[28]  E. Kavalali,et al.  NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses , 2011, Nature.

[29]  A. Mallinger,et al.  Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[30]  Nanxin Li,et al.  Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure , 2011, Biological Psychiatry.

[31]  Dost Öngür,et al.  Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders , 2010, Biological Psychiatry.

[32]  R. Dingledine,et al.  Glutamate Receptor Ion Channels: Structure, Regulation, and Function , 2010, Pharmacological Reviews.

[33]  C. Andrade,et al.  Innovative approaches to treatment - refractory depression: The ketamine story , 2010, Indian journal of psychiatry.

[34]  P. Skolnick,et al.  Glutamate-based antidepressants: 20 years on. , 2009, Trends in pharmacological sciences.

[35]  D. Charney,et al.  Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression , 2009, Biological Psychiatry.

[36]  R. Anwyl,et al.  Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. , 2009, The international journal of neuropsychopharmacology.

[37]  J. Krystal,et al.  The NMDA receptor as a therapeutic target in major depressive disorder. , 2007, CNS & neurological disorders drug targets.

[38]  P. Paoletti,et al.  NMDA receptor subunits: function and pharmacology. , 2007, Current opinion in pharmacology.

[39]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[40]  H. MacMillan,et al.  The relationship between childhood physical abuse and suicidality among depressed women: results from a community sample. , 2003, The American journal of psychiatry.

[41]  Victoria Arango,et al.  Serotonin 1A Receptors, Serotonin Transporter Binding and Serotonin Transporter mRNA Expression in the Brainstem of Depressed Suicide Victims , 2001, Neuropsychopharmacology.

[42]  B. Meldrum,et al.  Glutamate as a neurotransmitter in the brain: review of physiology and pathology. , 2000, The Journal of nutrition.

[43]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[44]  J. Johnson,et al.  Childhood abuse and neglect: specificity of effects on adolescent and young adult depression and suicidality. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[45]  P. Barbaresi,et al.  Neuronal and glial localization of NR1 and NR2A/B subunits of the NMDA receptor in the human cerebral cortex. , 1999, Cerebral cortex.

[46]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[47]  J. Kleinman,et al.  Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains , 1997, Synapse.

[48]  Anil K Malhotra,et al.  Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.

[49]  F. Conti Localization of NMDA receptors in the cerebral cortex: a schematic overview. , 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[50]  T. Kelly,et al.  Validity of DSM‐III‐R diagnosis by psychological autopsy: a comparison with clinician ante‐mortem diagnosis , 1996, Acta psychiatrica Scandinavica.

[51]  S. Lipton,et al.  NMDA receptors: from genes to channels. , 1996, Trends in pharmacological sciences.

[52]  J. John Mann,et al.  Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims , 1995, Brain Research.

[53]  G. Westbrook,et al.  Kinetics of AP5 dissociation from NMDA receptors: evidence for two identical cooperative binding sites. , 1994, Journal of neurophysiology.

[54]  C. Katona,et al.  NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides , 1993, Brain Research.

[55]  K. Frei,et al.  Macrophage‐induced cytotoxicity of N‐methyl‐D‐aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines , 1992, European journal of immunology.

[56]  J. D. Clements,et al.  Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-d-aspartate receptor , 1991, Neuron.

[57]  M. Mayer,et al.  Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine. , 1991, Biophysical journal.

[58]  Edythe D. London,et al.  Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia , 1991, Biological Psychiatry.

[59]  V. Arango,et al.  Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. , 1990, Archives of general psychiatry.

[60]  R. Dingledine,et al.  Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. , 1988, Science.

[61]  P. Ascher,et al.  Glycine potentiates the NMDA response in cultured mouse brain neurons , 1987, Nature.

[62]  G. Acosta Early Life Experience, Maternal Separation, and Involvement of GABA and Glutamate Transporters , 2018 .

[63]  V. Arango,et al.  Similar effects of glycine, zinc and an oxidizing agent on [3H]dizocilpine binding to the N-methyl-D-aspartate receptor in neocortical tissue from suicide victims and controls , 2005, Journal of Neural Transmission / General Section JNT.

[64]  J. Feldon,et al.  Long-term Biobehavioral Effects of Maternal Separation in the Rat: Consistent or Confusing? , 2000, Reviews in the neurosciences.

[65]  D. Bernstein,et al.  Childhood Trauma Questionnaire: A retrospective self-report , 1998 .